Leteurtre F - Search Results

1

Topoisomerase II inhibition and cytotoxicity of the anthrapyrazoles DuP 937 and DuP 941 (Losoxantrone) in the National Cancer Institute preclinical antitumor drug discovery screen.

Leteurtre F, Kohlhagen G, Paull KD, Pommier Y. Leteurtre F, et al. J Natl Cancer Inst. 1994 Aug 17;86(16):1239-44. doi: 10.1093/jnci/86.16.1239. J Natl Cancer Inst. 1994. PMID: 8040892

2

Azatoxin derivatives with potent and selective action on topoisomerase II.

Leteurtre F, Sackett DL, Madalengoitia J, Kohlhagen G, MacDonald T, Hamel E, Paull KD, Pommier Y. Leteurtre F, et al. Biochem Pharmacol. 1995 May 11;49(9):1283-90. doi: 10.1016/0006-2952(95)00047-4. Biochem Pharmacol. 1995. PMID: 7763310

3

Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors.

Pommier Y, Leteurtre F, Fesen MR, Fujimori A, Bertrand R, Solary E, Kohlhagen G, Kohn KW. Pommier Y, et al. Among authors: leteurtre f. Cancer Invest. 1994;12(5):530-42. doi: 10.3109/07357909409021413. Cancer Invest. 1994. PMID: 7922710 Review. No abstract available.

4

Streptonigrin-induced topoisomerase II sites exhibit base preferences in the middle of the enzyme stagger.

Leteurtre F, Kohlhagen G, Pommier Y. Leteurtre F, et al. Biochem Biophys Res Commun. 1994 Sep 15;203(2):1259-67. doi: 10.1006/bbrc.1994.2318. Biochem Biophys Res Commun. 1994. PMID: 8093042

5

Dual inhibition of topoisomerase II and tubulin polymerization by azatoxin, a novel cytotoxic agent.

Solary E, Leteurtre F, Paull KD, Scudiero D, Hamel E, Pommier Y. Solary E, et al. Among authors: leteurtre f. Biochem Pharmacol. 1993 Jun 22;45(12):2449-56. doi: 10.1016/0006-2952(93)90226-m. Biochem Pharmacol. 1993. PMID: 8392342

6

Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives.

Tanizawa A, Kohn KW, Kohlhagen G, Leteurtre F, Pommier Y. Tanizawa A, et al. Among authors: leteurtre f. Biochemistry. 1995 May 30;34(21):7200-6. doi: 10.1021/bi00021a035. Biochemistry. 1995. PMID: 7766631

7

Rational design and molecular effects of a new topoisomerase II inhibitor, azatoxin.

Leteurtre F, Madalengoitia J, Orr A, Guzi TJ, Lehnert E, Macdonald T, Pommier Y. Leteurtre F, et al. Cancer Res. 1992 Aug 15;52(16):4478-83. Cancer Res. 1992. PMID: 1322792

8

DNA recombinase activity of eukaryotic DNA topoisomerase I; effects of camptothecin and other inhibitors.

Pommier Y, Jenkins J, Kohlhagen G, Leteurtre F. Pommier Y, et al. Among authors: leteurtre f. Mutat Res. 1995 Sep;337(2):135-45. doi: 10.1016/0921-8777(95)00019-g. Mutat Res. 1995. PMID: 7565862

9

Interaction of an alkylating camptothecin derivative with a DNA base at topoisomerase I-DNA cleavage sites.

Pommier Y, Kohlhagen G, Kohn KW, Leteurtre F, Wani MC, Wall ME. Pommier Y, et al. Among authors: leteurtre f. Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8861-5. doi: 10.1073/pnas.92.19.8861. Proc Natl Acad Sci U S A. 1995. PMID: 7568032 Free PMC article.

10

Cellular pharmacology of azatoxins (topoisomerase-II and tubulin inhibitors) in P-glycoprotein-positive and -negative cell lines.

Eymin B, Solary E, Chevillard S, Dubrez L, Goldwasser F, Duchamp O, Genne P, Leteurtre F, Pommier Y. Eymin B, et al. Among authors: leteurtre f. Int J Cancer. 1995 Oct 9;63(2):268-75. doi: 10.1002/ijc.2910630221. Int J Cancer. 1995. PMID: 7591216

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters